Press Statements
Almac Announces Major Investment to Expand Singapore Facility
Almac announces multi-million-pound investment in Singapore
Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years...
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit
Data showed consistent improvements across secondary outcome measures, and a favorable...
Biobeat Report: CDMO Growth in China and USA for 2026
Biobeat report predicts CDMOs in China & USA to see fastest growth – with mAbs, PROTACs, ADCs & sterile filling in demand
AI’s VC funding...
VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products
The highest flexibility regarding products, containers, and closures
Half the footprint thanks to exchangeable modules and a high degree of automation
Identical machine...
AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 -- AbbVie and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") announced a definitive agreement under which AbbVie will...
Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF
Next-generation pharmaceutical glass tubing reduces carbon emissions by 50% thanks to innovative electric melting technology and 100% green electricity, helping pharmaceutical companies and...
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...